No, no. Affordability, even at our cost, which is as low as we can drive the cost down, is still great.
I think a question came up about PEPFAR as another source of funding. More money is needed to purchase products, even if they're generics, even if they're coming through our access program in Africa. Almost half the product being purchased in Africa is being supported by President Bush's PEPFAR initiative, the initiative of the United States; the vast majority of the rest of it is coming from the global fund. These countries can't even afford the cheapest products.